Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094118 · ClinicalTrials.gov registry record · Phase 1
Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 171
- Enrollment target
NCT02094118: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT02094118 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 171 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02094118, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 171 participants
- Enrollment target
Study Summary
This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
Interventions
- BIOLOGICAL Point-of-care washed red blood cell transfusion.
- BIOLOGICAL Standard of care red blood cell transfusion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-05-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02094118
The ClinicalTrials.gov registry entry for NCT02094118 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Point-of-care washed red blood cell transfusion. is the first listed.
NCT02094118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02094118 about?
NCT02094118 is a clinical study titled "Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications". This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
What is the current status of trial NCT02094118?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 171 participants. The study started on 2016-01. Estimated completion is 2019-05-30.
What interventions are being tested in trial NCT02094118?
The interventions under investigation include: Point-of-care washed red blood cell transfusion. (BIOLOGICAL), Standard of care red blood cell transfusion. (BIOLOGICAL).
Who is sponsoring clinical trial NCT02094118?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.